BioAtla, Inc. (BCAB) vs Cullinan Therapeutics, Inc. (CGEM)
Detailed comparison between BioAtla, Inc., Cullinan Therapeutics, Inc..Total Return (%)
BioAtla, Inc. (BCAB)Cullinan Therapeutics, Inc. (CGEM)
Which stock do you think will perform better?
BioAtla, Inc.
BCAB
Cullinan Therapeutics, Inc.
CGEM
| Metric | BioAtla, Inc. (BCAB) | Cullinan Therapeutics, Inc. (CGEM) |
|---|---|---|
| Current Price | $0.37 | $7.69 |
| Change | 0.00 (0.58%) | -0.08 (-1.03%) |
| Market Cap | $0.02B | $0.45B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -0.25 | -2.37 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $2.52 | $21.01 |
| 52-Week Low | $0.24 | $6.85 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.22 | $-2.77 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| BCAB | -7.06% | -26.20% | -78.08% | -98.80% | -98.80% | -98.80% |
| CGEM | 0.26% | -26.20% | -57.96% | -74.29% | -74.29% | -74.29% |